ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Corgi All World 2x Daily ETF
25.03
+0.2788
1.13%
成交量:
11
成交額:
299
市值:
37.54萬
市盈率:
- -
高:
25.03
開:
24.75
低:
25.03
收:
24.75
52周最高:
25.58
52周最低:
20.48
股本:
1.50萬
流通股本:
1.50萬
量比:
0.03
換手率:
0.07%
股息:
- -
股息率:
- -
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
CXO與創新藥協同共振步入收穫季,借港股通創新藥ETF嘉實一鍵佈局全產業鏈
新浪基金
·
1小時前
ETF日報:創新藥與CXO仍然是當前醫藥板塊景氣度最高的兩條主線
新浪基金
·
08/20
CXO概念有支撐 凱萊英(06821)漲2.27% 金斯瑞生物科技(01548)漲2.41%
金吾财讯
·
08/19
國產創新藥迎三重業績拐點 CXO龍頭利潤與訂單同步創出歷史新高
智通财经
·
08/19
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/WX"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"WX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WX\",,,,,undefined,":{"symbol":"WX","market":"US","secType":"STK","nameCN":"Corgi All World 2x Daily ETF","latestPrice":25.0259,"timestamp":1787342400000,"preClose":24.7471,"halted":0,"volume":11,"delay":0,"changeRate":0.01126596651728891,"floatShares":15000,"shares":15000,"eps":0,"marketStatus":"盤前交易","change":0.2788,"latestTime":"08-24 06:06:21 EDT","open":24.7471,"high":25.0259,"low":25.0259,"amount":299,"amplitude":0,"askPrice":39.79,"askSize":100,"bidPrice":10.06,"bidSize":100,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"exchange":"CBOE","adjPreClose":25.0259,"nav":24.75,"aum":371250,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":24.7471,"preClose":25.0259,"latestTime":"16:10 EDT","volume":4,"amount":100.1036,"timestamp":1787343004531,"change":-0.2788,"changeRate":-0.01114,"amplitude":0},"volumeRatio":0.026353627734979485},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WX\",,,,,undefined,":{"symbol":"WX","floatShares":15000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.026353627734979485,"shares":15000,"dividePrice":0,"high":25.0259,"amplitude":0,"preClose":24.7471,"low":25.0259,"week52Low":20.48,"pbRate":"--","week52High":25.58,"institutionHeld":0,"latestPrice":25.0259,"eps":0,"divideRate":0,"volume":11,"delay":0,"ttmEps":0,"open":24.7471,"prevYearClose":24.72,"prevWeekClose":25.0259,"prevMonthClose":23.7081,"prevQuarterClose":23.5672,"fiveDayClose":25.4996,"twentyDayClose":23.1847},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/WX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"WX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"WX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"WX\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661922977","title":"CXO與創新藥協同共振步入收穫季,借港股通創新藥ETF嘉實一鍵佈局全產業鏈","url":"https://stock-news.laohu8.com/highlight/detail?id=2661922977","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661922977?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 16:07","pubTimestamp":1787558820,"startTime":"0","endTime":"0","summary":"多家尚未登陆 A 股的创新药、CXO 龙头汇聚港股市场,普通投资者想要把握这一轮产业机遇,或可锚定覆盖港股创新药全产业链、CXO含量较高的港股通创新药ETF嘉实及其联接基金来一键布局。如果场内投资者想高效把握港股创新药和CXO龙头的高景气,港股通创新药ETF嘉实或更适配,其支持场内T+0交易,投资效率更高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2026-08-24/doc-inipkzxs2033792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","LNGR","IBBQ","CXO","520970","159992","BK1574","MEDX","06978","WX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660428206","title":"ETF日報:創新藥與CXO仍然是當前醫藥板塊景氣度最高的兩條主線","url":"https://stock-news.laohu8.com/highlight/detail?id=2660428206","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660428206?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 21:08","pubTimestamp":1787231280,"startTime":"0","endTime":"0","summary":"受该里程碑临床进展催化,隔夜莫德纳股价大涨近180%,直接带动A股、港股创新药及疫苗板块情绪回暖。基本面角度,创新药与CXO仍然是当前医药板块景气度最高的两条主线。创新药与CXO板块景气度有望延续,感兴趣的投资者可关注20CM弹性的创业板医药ETF与科创创新药ETF;一键布局港股创新药与CXO龙头的恒生生物科技ETF;以及聚焦A股疫苗相关龙头的疫苗ETF。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-20/doc-ininynce8002615.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","159938","BK4588","MEDX","06978","BK1574","FDN","LNGR","BK4550","BK1161","WX","IBBQ","CXO","09939","159992","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660419923","title":"CXO概念有支撐 凱萊英(06821)漲2.27% 金斯瑞生物科技(01548)漲2.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660419923","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660419923?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 10:53","pubTimestamp":1787108028,"startTime":"0","endTime":"0","summary":"金吾财讯 | CCXO概念有支撑,凯莱英 涨2.27%、金斯瑞生物科技涨2.41%、百济神州涨0.63%、方达控股涨0.79%、药明生物涨0.04%爱建证券表示,2026年初以来医药板块的持续回调与行业基本面、产业趋势发生背离,近期众多上市公司推出现金回购和增持方案,反映出对产业未来发展的充足信心,CXO、创新药及相关产业链已率先发力反弹,医药板块中长期布局良机已至。同时,该机构看好高景气CXO、器械出海、脑机接口、AI+医疗等投资机会。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1988641","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269","LU1242518931.SGD","LU0043850808.USD","LU0359202008.SGD","LU0359201612.USD","LU0181495838.USD","06160","LU1720050803.USD","LU0516422440.USD","LU0320764599.SGD","06821","LU1688375341.USD","LU0052750758.USD","WX","KURE","LU0828237510.HKD","LU0348825331.USD","LU0708995583.HKD","LU0516423091.SGD","LU0128526141.USD","LU1770034418.SGD","LU0417516738.SGD","LU0819121731.USD","CXO","HK0000320223.HKD","LU0140636845.USD","01521","LU0516422366.SGD","LU1969619763.USD","HK0000306685.HKD","LU0417516902.SGD","BK1191","LU1719994722.HKD","BK1588","BK1589","LU0456827905.SGD","LU0572944931.SGD","BK1500","SG9999002463.SGD","BK1576","LU2328871848.SGD","LU0588546209.SGD","LU0228659784.USD","LU0039217434.USD","002821","01548","BK1141","BK1610","LU3063872942.SGD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660490014","title":"國產創新藥迎三重業績拐點 CXO龍頭利潤與訂單同步創出歷史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490014","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660490014?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 07:25","pubTimestamp":1787095509,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","MEDX","WX","CXO","LNGR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":9,"pageCount":1,"totalSize":34,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/WX\",params:#limit:6,delay:false,,,undefined,":[]}}